ReviewCurrent cardiology reports2026
Multimodality Imaging in Myocarditis: Integrating Etiology, Diagnosis, and Risk Stratification.
Review in Current cardiology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewMyocarditis presents with heterogenous clinical manifestations and remains diagnostically challenging due to nonspecific biomarkers and limitations of endomyocardial biopsy. This review evaluates the role of multimodality cardiac imaging in the diagnosis, phenotyping, and longitudinal management of myocarditis, and proposes a practical clinical integration pathway. RECENT
findingsCardiac magnetic resonance has emerged as the reference noninvasive modality, with parametric mapping and updated Lake Louise Criteria improving diagnostic sensitivity and prognostic stratification. Echocardiographic strain imaging enhances detection of subclinical dysfunction. Positron emission tomography enables assessment of active inflammation, particularly in sarcoidosis and immune checkpoint inhibitor-associated myocarditis. Advances in photon-counting CT, hybrid PET/MR, and artificial intelligence are expanding tissue characterization and risk prediction capabilities. A stepwise imaging strategy integrating echocardiography, CMR, PET, and CT improves diagnostic confidence and guides tailored management. Ongoing research focused on imaging biomarker standardization, validation, and outcome prediction will further refine precision care in myocarditis.
Indexed as
Identifiers
42126698What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.